Follow
Founded: 1986
Owner: Hasmukh Chudgar
Headquarters: Ahmedabad
Revenue: $1.49 billion (FY20)
Intas Pharmaceuticals Limited, based in Ahmedabad was founded in 1984 and has a revenue of $1.49 billion as in 2020. It has 13 commercialized biosimilars including Docetaxel and Paclitaxel. This pharma company in India has its R&D department in the field of chronic disease of oncology (cancer), rheumatology, auto-immune, nephrology, ophthalmology, and plasma-derived product-based therapies.
This pharmaceutical company has its headquarters in Ahmedabad and is one of the leading biosimilar product manufacturers in Asia. Intas has 14 formulation manufacturing facilities, of which seven are located in India and the rest in the UK. and Mexico. It is the seventh-largest company in India, and the company saw an increase in revenue by 29.84% in 2017.
